Show simple item record

Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study

dc.creatorLondon, Cheryl A.
dc.creatorBernabe, Luis Feo
dc.creatorBarnard, Sandra
dc.creatorKisseberth, William C.
dc.creatorBorgatti, Antonella
dc.creatorHenson, Mike
dc.creatorWilson, Heather
dc.creatorJensen, Kiersten
dc.creatorIto, Daisuke
dc.creatorModiano, Jaime F.
dc.creatorBear, Misty D.
dc.creatorPennell, Michael L.
dc.creatorSaint-Martin, Jean-Richard
dc.creatorMcCauley, Dilara
dc.creatorKauffman, Michael
dc.creatorShacham, Sharon
dc.creatorRichards, Kristy L.
dc.date.accessioned2019-10-17T18:36:50Z
dc.date.available2019-10-17T18:36:50Z
dc.date.issued2014
dc.identifier.issn1932-6203
dc.identifier.urihttps://hdl.handle.net/1969.1/185386
dc.format.extent0en
dc.publisherPloS One
dc.relation.ispartof1foldr Import 2019-10-08 Batch 10en
dc.relation.uri10.1371/journal.pone.0087585en
dc.titlePreclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Studyen


Files in this item

Thumbnail
Name:
document-1.pdf
Size:
1.729Mb
Format:
PDF
View/ Open

This item appears in the following Collection(s)

Show simple item record